PSA free percent
Selected indexed studies
- The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer. (Semin Urol Oncol, 1998) [PMID:9741413]
- Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH. (Hinyokika Kiyo, 1998) [PMID:9617617]
- The use of percent free PSA for early detection of prostate cancer. (J Androl, 1999) [PMID:10452585]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). (2024) pubmed
- Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial. (2023) pubmed
- The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer. (1998) pubmed
- Prostate cancer probability after total PSA and percent free PSA determination. (1998) pubmed
- Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH. (1998) pubmed
- The use of percent free PSA for early detection of prostate cancer. (1999) pubmed
- Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities. (2019) pubmed
- Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. (2000) pubmed
- Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. (1998) pubmed
- Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis. (2008) pubmed